Reference 18 - Bioequivalence Studies for Generic Drug Development
FDA-2026-P-6541-0020Supporting & Related Material
Document
Details
The document's own metadata, straight from the source system.
- Title
- Reference 18 - Bioequivalence Studies for Generic Drug Development
- Posted
- Jun 9, 2026
- Topics